Linked Life Data

1528485

Source:http://linkedlifedata.com/resource/pubmed/id/1528485

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1992-10-22
pubmed:abstractText
Development of medical countermeasures for chemical and biological threats is a mission of the U.S. Army Medical Research and Development Command. Several such countermeasures were fielded during Operation Desert Shield/Storm and a controversy developed in the press and in the courts over the use of these "experimental drugs" in service members. Far from experimental, these drugs were, however, fielded as "investigational" products. Describing the products as investigational is a result of Food and Drug Administration regulations, not a comment on the extent to which the products have been tested.
pubmed:commentsCorrections
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
E
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0026-4075
pubmed:author
pubmed:issnType
Print
pubmed:volume
157
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
404-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Investigational drugs and vaccines fielded in support of Operation Desert Storm.
pubmed:affiliation
Human Use Review and Regulatory Affairs Office, Fort Detrick, Frederick, MD 21702.
pubmed:publicationType
Journal Article